Predictive values for procalcitonin in the diagnosis of neonatal sepsis
Keywords:
Procalcitonin, C-reactive protein, Neonatal sepsisAbstract
Background: Early diagnosis of neonatal sepsis followed by appropriate treatment decreases mortality and morbidity in infants. The aim of this study is to assess the role of procalcitonin (PCT) as a marker in the early diagnosis of neonatal sepsis.
Methods: We present a cross sectional study where 35 neonates with early onset sepsis (admitted to the Neonatal Intensive Care Units at El-Minia Children University Hospital from August 2012 to August 2013) were included in the study. Another 35 healthy neonates with no clinical or biological data of infection were included as a control group. Subjects were subjected to a thorough history taking and routine laboratory investigations. Serum PCT and C-reactive protein (CRP) levels were determined by enzyme-linked immunosorbent assay (ELISA).
Results: Mean levels of PCT and CRP in neonates with sepsis were significantly higher than in the control group (p=0.0001). There was a moderate, but significant, positive correlation between PCT and C-reactive protein (p=0.001, r=0.55) and an insignificant correlation between procalcitonin and total leukocytic count among the neonates with sepsis (p=0.2, r=0.2). In addition, procalcitonin had high sensitivity, specificity, a high positive predictive value, and a high negative predictive value (80%, 85.7%, 84.8%, and 81.1% respectively). Procalcitonin showed higher sensitivity when compared to CRP.
Conclusion: Procalcitonin is a sensitive, independent, and useful biomarker in comparison to CRP in early diagnosis of neonatal sepsis.
References
Barbara S. Infections of the neonatal infant. In: Behrman Re, Kliegman R, Jensen HB, editors. Behrman:
Nelson Textbook of Pediatrics. Philadelphia: WB Saunders CO; 2008;794-811.
Young LS. Sepsis syndrome. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of
Infectious Diseases. Philadelphia: Churchill livingstone; 2005; 910-920.
Remington JS, Klein JO, Wilson CB, et al. Infectious diseases of fetuses and newborn infants. N Engl J
Med 2006; 355:531-2
Chiesa C, Panero A, Rossi A, Buffone E, Tramontezzi P, Osborn JF, et al; Reliability of procalcitonin
concentrations for the diagnosis of sepsis in critically ill neonates. CID 1998; 26: 664-72.
Assicot M, Gendrel D, Carsin H. High serum procalcitonin concentrations in patients with sepsis and
infection. Lancet 1993; 341: 515-18.
Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38:
-93. doi: 10.1177/000456320103800505, PMid: 11587126
Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation
immunochemical characterization. J invest med 1997; 45: 552-60.
Bohuon C, Gendrel D. Procalcitonin. A new indicator for bacterial infection. Interest and perspectives.
Arch Pediatr 1999; 6: 141-4.
Dandona P, Nix D, Wilson MF. Procalcitonin increase after endotoxin injection in normal subjects. J Clin
Endocrinol Metab 1994; 79: 1605-8.
Monneret G, Labaune JM, Isaac C, Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J.
Procalcitonin and C- reactive protein levels in neonatal infections. Acta Pediatr 1997; 86: 209-12.
Gibbs RS. Obstetric factors associated with infections of the fetus and newborn infant. In: Remington JS,
Klein JO, eds. Infectious diseases of the fetus and newborn infant, 4th Ed. Philadelphia. Saunders 1995;
: 63.
Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of
early acute respirator syndrome by procalcitonin. Crit Care Med 1999; 27: 2172-6.
Eberhard OK, Haubitz M, Brunkhorst FM. Usefulness of procalcitonin for differentiation between activity
of systemic autoimmune disease (systemic lupus erythematosus/systemic anti neutrophil cytoplasmic
antibody associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-6.
Naher BS, Mannan MA, Noor K, Shahiddullah M Role of serum procalcitonin and C-Reactive Protein in
the diagnosis of neonatal sepsis. Bangladesh Med Res Counc Bull 2011; 37: 40-6. doi:
3329/bmrcb.v37i2.8432, PMid: 21877603
Stoll BJ. , Hansen NI. , Sanchez PJ. Early onset neonatal sepsis : the burden of group B streptococcal
and E.coli disease continues, Pediatrics, 2011 ; 127(5);817–26. doi: 10.1542/peds.2010-2217, PMid:
PMCid: PMC3081183
Baruti-Gafurri ZH. Paçarizi, BZ. The importance of determining procalcitonin and C-reactive protein in
different stages of sepsis. Bosnian Journal of basic medical sciences, 2010;10 (1): 60-4. PMid: 20192933
Enguix AC. Rey CA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early
diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211-5
Washburn TC, Mede; aris DN, Childs B. Sex differences in susceptibility to infections. Pediatrics 1965: 57- 64. 19.
Reghavan M, Mondal GP, Bhat BV, Meisner Michael. Perinatal risk factors in neonatal infections. Indian J
Pediatr 1992; 59: 335-40
Tuuli MG, Ohio AO. Neonatal outcomes in relation to timing of repeat cesarean delivery at term. Womens
Health (Lond Engl) 2009; 5:239-42. doi: 10.2217/whe.09.5, PMid: 19392609
Afsharpaiman SM, Amin S, Amir F,Amirsalari S, Kavehmanesh Z Neonatal sepsis and antibiotic
susceptibility in two Neonatal Intensive Care Units in Iran . Journal of Clinical Neonatology 2012; 1(3),
-78.
Basu S, Guruprasad, Narang A, Garewal G. The diagnosis of sepsis in high risk neonates by using a
hematologic scoring system. Indian J Hematolo Blood Transfusion 1999; 17:32-34.
Srinivasan L. and Harris M.C. New technologies for the rapid diagnosis of neonatal sepsis. Curr Opin
Pediatr, 2012;24, 2;165-71. doi: 10.1097/MOP.0b013e3283504df3, PMid: 22273634
Laurent R, Caroline S, Eric K, D’herbomez M, Fourrier F. A composite score combining procalcitonin, Creactive protein and temperature has a high positive predictive value for the diagnosis of intensive care- acquired infections. BMC Infectious Diseases 2013; 13:159. doi: 10.1186/1471-2334-13-159, PMid:
PMCid: PMC3655912
Chiesa C, Signore F, Assumma M, Buffone E, Tramontezzi P, Osborn JF. Serial measurements of the C
reactive protein and interleukin 6 in the immediate postnatal period: the reference intervals and the analysis
of the maternal and the perinatal confounders. Clin Chem 2001;47:1016–22.
Naglaa FB, Abeer S, Mohammad A Laila M. Procalcitonin and C- Reactive Protein as Diagnostic Markers
of Neonatal Sepsis. Australian Journal of Basic and Applied Sciences, 2012; 6(4): 108-14.
Nora H, Wilhelm M, Bernhard R. The Role of C-Reactive Protein in the Diagnosis of Neonatal Sepsis.
Licensee InTech 2013; 10(5)752-55.
Koksal N, Harmanci R, Getinkaya M. The roles of procalcitonin and CRP in the diagnosis and the follow
up of neonatal sepsis cases. Turk J Paediatr 2007; 49:21-9.
Zahedpasha Y, Ahmad K M, Hajiahmadi M, Haghshenas M. Procalcitonin as a marker of neonatal sepsis.
Iran J Paediatr; 2009;19:117-22.
Sucilathangam G, Amuthavalli K, Velvizhi G Ashihabegum M.A, Jeyamurugan T Palaniappan N; Early
Diagnostic Markers For Neonatal Sepsis: Comparing Procalcitonin and C-Reactive Protein Journal of
Clinical and Diagnostic Research. 2012;6 (4) :627-31.
Dimple A, Sabari D, Mohan S: Procalcitonin: A Novel Sepsis Biomarker. Asian J Med Res 2012; 1(1);
-7
Vincent JL, Mercan DD; what is your PCT? Intensive Care Med, 2000; 26:1170-1.
Lobo SM, Lobo FR, Bota DP, Soliman HM, Melot C, Vincent JL. C-reactive protein levels correlate with
mortality and organ failure in critically ill patients. Chest, 2003;123: 2043-9
Mamdouh ME, Ahmed H, Hoda M. Abdelrahim AS Procalcitonin or C-reactive protein or both for
diagnosis of neonatal sepsis? Journal of Applied Sciences Research, 2012; 8(8): 4615-23.
Wang H, Fan Y, Ding-Xia S, Wang K, Zhou G, Li-Yan Y, Gang C Xiao-Ning W Predictive value of
procalcitonin for excluding bloodstream infection: Results of a retrospective study and utility of a rapid,
quantitative test for procalcitonin. Journal of International Medical Research 2013; (24) 1–11
Wa'ad MR, Mousa JM, Emad R.A, Suha MA. Evaluation of Procalcitonin Test for Early Diagnosis of
Neonatal Sepsis in Tikrit Teaching Hospital. J. of university of anbar for pure science 2010;.4(3);234-8.
Pavcnik-Arnol M, Hojker M. D. Lipopolysaccharide-binding protein in critically ill neonates and children
with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein Intensive
Care Med., 2004;.30: 1454- 60
Ivančević N, Radenković D, Bumbaširević V, et al. Procalcitonin in preoperative diagnosis of abdominal
sepsis. Langenbeck's Arch Surg. 2007; 39(3): 397-403.
Jimenez AJ, Palomo DL, Reyes MJ. Guerrero AP, Miguez RP Martinez SR. Utility of procalcitonin and Creactive protein in the septic patient in the emergency department. Emergencias 2009; 21: 23-27.
Janota J, Stranak Z, Belohlavkova S. Postnatal increase of procalcitonin in premature newborns is enhanced
by chorioamnionitis and neonatal sepsis. Eur J Clin Invest 2001; 31:978-83.
Vazzalwar R, Pina‐Rodrigues E, Puppala BL. Procalcitonin as a screening test for late‐onset sepsis in
preterm very low birth weight infants. J Peditr 2005; 25(6):397‐402
Abdollahi AS. Shoar FN, Shariat M. Diagnostic value of simultaneous measurement of Procalcitonin,
Interleukin-6 and -CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis. 2012; 4;
(2).345-9.
Sakha K, Husseini MB, Seyyedsadri N. The role of procalcitonin in the diagnosis of neonatal sepsis and the
correlation between procalcitonin and C-reactive protein in these patients. Pak J Biol Sci 2008; 11:1785- 90.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
